View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Research Department
  • Research Department

INFORME DIARIO 25 NOVIEMBRE (ANÁLISIS BANCO SABADELL)

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CELLNEX. EUROPA: UNICREDIT, VINCI. Otra semana más con EE.UU. haciéndolo mejor Una semana más EE.UU. cierra en positivo mientras Asia registró caídas y Europa terminó con signo mixto donde el FTSE y el SMI fueron los mejores y el CAC y MIB los peores. Dentro del STOXX 600, Media y Farma lideraron las ganancias mientras que los Bancos fueron los que más cayeron (>-2,0%), seguidos de Viajes&Ocio y Autos. Por el lado macro, Eurozona los PMIs prelimin...

Research Department
  • Research Department

IBERIAN DAILY 25 NOVEMBER (ANÁLISIS BANCO SABADELL)

NEWS SUMMARY: CELLNEX. Another week with the US leading the way It was another week with the US closing in positive numbers, whereas Asia saw losses and Europe ended with mixed performance, where the FTSE and SMI were the best performers and the CAC and MIB the worst. In the STOXX 600, Media and Pharma led the gains, while Banks saw the biggest drops (more than -2.0%), followed by Travel & Leisure and Autos. On the macro side, in the euro zone November’s preliminary manufacturing and services P...

Andres Bolumburu
  • Andres Bolumburu

CAF: RDOS. 9MESES’24 (ANÁLISIS BANCO SABADELL)

Rdos. 3T'24 vs 3T'23: Ventas: 838,0 M euros (-2,3% vs +9,7% BS(e) y +11,3% consenso); EBIT: 35,0 M euros (-18,6% vs +16,7% BS(e) y +16,3% consenso); BDI: 9,0 M euros (-52,6% vs +47,4% BS(e) y +36,8% consenso); Rdos. 9meses'24 vs 9meses'23: Ventas: 2.918 M euros (+6,7% vs +10,5% BS(e) y +11,0% consenso); EBIT: 137,0 M euros (+7,0% vs +18,9% BS(e) y +18,8% consenso); BDI: 61,0 M euros (+15,1% vs +50,9% BS(e) y +47,2% consenso);

Research Department
  • Research Department

INFORME DIARIO 15 NOVIEMBRE + RDOS. ESPAÑA 3T’24. PREVIEWS (ANÁLISIS B...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACCIONA, ACCIONA ENERGÍA, CAF, CAIXABANK, COLONIAL, MERLIN. EUROPA: ASML, SANOFI. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’24 que se publicarán en España y Europa en los próximos días. El BCE con el objetivo casi cumplido El Euro STOXX 50 tuvo su mejor día desde finales de septiembre mientras las ...

Research Department
  • Research Department

IBERIAN DAILY 13 NOVEMBER + 3Q’24 RESULTS. HIGHLIGHTS AND REST OF PREV...

NEWS SUMMARY: ACS, AENA, CAF, GREENING, NEINOR HOMES, REAL ESTATE SECTOR, SACYR. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 3Q’24 results to be released over the coming days in Spain. Germany to hold elections in February The contagion from Asia, along with the increased geopolitical risk, dragged down European stock markets. In the STOXX 600, only Technology ended in gree...

Andres Bolumburu
  • Andres Bolumburu

CELLNEX: MENSAJES DE LA CONFERENCE CALL RDOS. 3T'24 (ANÁLISIS BANCO SA...

De la conference call de Rdos. 3T’24, destacamos los siguientes mensajes:  Aceleración remuneración al accionista

James Ratzer
  • James Ratzer

Cellnex (Neutral, €31, -8%) Q3 24 - Potential consolidation changes a...

Cellnex’s Q3 financial results were all fine with guidance reiterated, albeit underlying tenancy and small cell growth still remains modest.

Carole Braudeau
  • Carole Braudeau

Morning Crédit 11/11/2024

Q4 23 results: Conti lowers guidance again, albeit adj. EBIT improves Kion : new EUR 500m senior unsecured bond>...

Carole Braudeau
  • Carole Braudeau

Credit Morning 11/11/2024

Q4 23 results: Conti lowers guidance again, albeit adj. EBIT improves Kion : New EUR 500m senior unsecured bond>...

Ana Arjona-Martinez
  • Ana Arjona-Martinez

Cellnex : Results completely in line; short and mid-term guidance reit...

>EBITDAaL just 0.7% and 0.9% above our estimates and the consensus - Cellnex’s Q3 2024 results were in line with our estimates and with the consensus at the operating level: revenues at € 982m (€ 987m ODDO BHF and € 982m css), with a slightly weaker performance from DAS and Services compensated by a better performance in France (probably partially impacted by the timing of the disposal of remedies within the quarter). An in-line performance in both opex and lease lia...

Andres Bolumburu
  • Andres Bolumburu

CELLNEX: 9M’24 RESULTS (ANÁLISIS BANCO SABADELL)

3Q'24 vs. 3Q'23 Results Sales: € 982.0 M (-2.5% vs. -2.8% BS(e) and -2.5% consensus); EBITDA: € 809.0 M (+6.7% vs. +6.2% BS(e) and +6.3% consensus); 9M'24 vs. 9M'23 Results Sales: € 2.903 Bn (-3.5% vs. -3.6% BS(e) and -3.5% consensus); EBITDA: € 2.387 Bn (+6.2% vs. +6.0% BS(e) and +6.0% consensus); Net Profit: € -140.0 M (€ -198.0 M in 9M'23);

Jan Frederik Slijkerman ... (+5)
  • Jan Frederik Slijkerman
  • Jeroen van den Broek
  • Jesse Norcross
  • Nadège Tillier
  • Timothy Rahill
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch